US Patent Issued to AMGEN, Vigil Neuroscience on March 18 for "Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use" (California, Massachusetts Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,252,489, issued on March 18, was assigned to AMGEN Inc. (Thousand Oaks, Calif.) and Vigil Neuroscience Inc. (Cambridge, Mass.).

"Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use" was invented by Lara C. Czabaniuk (Thousand Oaks, Calif.), Timothy Hopper (Thousand Oaks, Calif.), Jonathan B. Houze (Cambridge, Mass.), Gwenaella Rescourio (Thousand Oaks, Calif.), Vincent Santora (Thousand Oaks, Calif.), Haoxuan Wang (Thousand Oaks, Calif.), Ryan D. White (Thousand Oaks, Calif.), Alice R. Wong (Thousand Oaks, Calif.) and Yongwei Wu (Thousand Oaks, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The ...